F. M. Schabel - Concepedia

Author

F. M. Schabel

Also Known As

F M SCHABEL, F M Schabel, F Schabel, F. M. Schabel, F. Maria Schabel, F. Schabel, F.D. Daschner, F.M. Schabel, F.M. Schabel Jr., F.M. Schabel, jr.

106

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Southern Research Institute

About

F. M. Schabel is an author at Southern Research Institute specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	3.4K
2	Natural Sciences	4	4	283
3	Health Sciences	2	2	51
4	Education	1	1	27
5	Engineering	1	1	332

F. M. Schabel

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. Howard E. Skipper, F. M. Schabel, W. S. Wilcox PubMed Hematological MalignancyExperimental LeukemiaMedicinePharmacologyPathology	1964	766
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Thomas H. Corbett, Daniel P. Griswold, Bill J. Roberts, PubMed ImmunologyPathologyTumor Induction RelationshipsCancer BiologyTumor Biology	1975	600
Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Thomas H. Corbett, Bill J. Roberts, Wilbur R. Leopold, PubMed ImmunologyPathologyPancreas TransplantationPanc 02Tumor Biology	1984	357
Concepts for systemic treatment of micrometastases F. M. Schabel Cancer Population SizeEngineeringAnalytical MicrosystemsPathologyMetronomic Chemotherapy	1975	332
The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A) F. M. Schabel Chemotherapy Bioorganic ChemistryAntiviral ActivityMedicineAntiviral Drug DevelopmentAntiviral Drug	1968	206
Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas T.H. Corbett, Daniel P. Griswold, Bill J. Roberts, Cancer ImmunologyPathologyBiological TherapyPharmacotherapyImmunotherapy	1977	182
Quantitative evaluation of anticancer agent activity in experimental animals F. M. Schabel, Daniel P. Griswold, W R Laster, Pharmacology & Therapeutics Part A Chemotherapy Toxicology and Metabolic Inhibitors Anticancer Agent ActivityPreclinical Drug EvaluationChemoprevention StrategyMedicinePharmacology	1977	113
Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenine R W Brockman, F. M. Schabel, John A. Montgomery Biochemical Pharmacology Biologic ActivityBioorganic ChemistryBiochemistryNatural SciencesMedicine	1977	107
Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole. R W Brockman, Sue C. Shaddix, W R Laster, PubMed L1210 LeukemiaSummary GuanazolePharmaceutical ChemistryTumor BiologyMedicinal Chemistry	1970	80
Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms. Howard E. Skipper, John A. Montgomery, J. R. Thomson, PubMed Experimental NeoplasmsBiochemistryMedicinePurine AnalogsNatural Sciences	1959	78

Page 1